CDMO News
Diverchim Acquires Innoverda to Advance Sustainable Drug Substance Development
Diverchim, a renowned French Contract Development and Manufacturing Organization (CDMO), has announced the acquisition of Innoverda, a Contract Research Organization (CRO) known for its electrochemical process solutions. The deal merges Diverchim’s strengths in drug substance development with Innoverda’s expertise in
20 January 2025